RESULTS OF SINGLE-AGENT AND COMBINATION CHEMOTHERAPY FOR ADVANCED SOFT-TISSUE SARCOMAS - IMPLICATIONS FOR DECISION-MAKING IN THE CLINIC

被引:85
作者
DEMETRI, GD
ELIAS, AD
机构
关键词
D O I
10.1016/S0889-8588(18)30070-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytotoxic chemotherapy remains the principal modality of treating advanced or unresectable sarcomas of soft tissue. Certain drugs, such as doxorubicin and ifosfamide, are able to induce clinically useful antitumor effects as single agents, and combination chemotherapy regimens have been tested based upon these results. This article summarizes the results of single agent and combination chemotherapy trials for soft tissue sarcomas.
引用
收藏
页码:765 / 785
页数:21
相关论文
共 137 条
[1]   ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN IN HIGH-GRADE SOFT-TISSUE SARCOMA - A RANDOMIZED TRIAL OF THE SCANDINAVIAN-SARCOMA-GROUP [J].
ALVEGARD, TA ;
SIGURDSSON, H ;
MOURIDSEN, H ;
SOLHEIM, O ;
UNSGAARD, B ;
RINGBORG, U ;
DAHL, O ;
NORDENTOFT, AM ;
BLOMQVIST, C ;
RYDHOLM, A ;
STENER, B ;
RANSTAM, J .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1504-1513
[2]   PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL OF ADJUVANT DOXORUBICIN FOR SARCOMAS - LACK OF APPARENT DIFFERENCE BETWEEN TREATMENT GROUPS [J].
ANTMAN, K ;
SUIT, H ;
AMATO, D ;
CORSON, J ;
WOOD, W ;
PROPPE, K ;
HARMON, D ;
CAREY, R ;
GREENBERGER, J ;
BLUM, R ;
WILSON, R .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) :601-608
[3]   AN INTERGROUP PHASE-III RANDOMIZED STUDY OF DOXORUBICIN AND DACARBAZINE WITH OR WITHOUT IFOSFAMIDE AND MESNA IN ADVANCED SOFT-TISSUE AND BONE SARCOMAS [J].
ANTMAN, K ;
CROWLEY, J ;
BALCERZAK, SP ;
RIVKIN, SE ;
WEISS, GR ;
ELIAS, A ;
NATALE, RB ;
COOPER, RM ;
BARLOGIE, B ;
TRUMP, DL ;
DOROSHOW, JH ;
AISNER, J ;
PUGH, RP ;
WEISS, RB ;
COOPER, BA ;
CLAMOND, GH ;
BAKER, LH .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1276-1285
[4]  
ANTMAN K, 1987, ADJUVANT THERAPY CAN, V5, P725
[5]  
ANTMAN K, 1985, CANCER TREAT S, V3, P109
[6]  
ANTMAN K, 1989, CANCER PRINCIPLES PR, P1345
[7]   RESPONSE TO IFOSFAMIDE AND MESNA - 124 PREVIOUSLY TREATED PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA [J].
ANTMAN, KH ;
RYAN, L ;
ELIAS, A ;
SHERMAN, D ;
GRIER, HE .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :126-131
[8]  
ANTMAN KH, 1984, ADJUVANT THERAPY CAN, V4, P611
[9]   EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION [J].
ANTMAN, KS ;
GRIFFIN, JD ;
ELIAS, A ;
SOCINSKI, MA ;
RYAN, L ;
CANNISTRA, SA ;
OETTE, D ;
WHITLEY, M ;
FREI, E ;
SCHNIPPER, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) :593-598
[10]  
BAKER A R, 1988, P123